NCI, Inc. (NASDAQ:NCIT)‘s stock had its “buy” rating restated by investment analysts at Noble Financial in a report issued on Friday, May 12th.
Several other research analysts have also issued reports on NCIT. FBR & Co reiterated a “hold” rating and issued a $11.00 price target on shares of NCI in a research note on Tuesday, April 4th. Zacks Investment Research lowered shares of NCI from a “hold” rating to a “sell” rating in a research note on Saturday, April 8th. Finally, Cowen and Company reissued a “buy” rating and set a $16.50 price objective on shares of NCI in a research report on Monday, April 10th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. NCI presently has an average rating of “Buy” and a consensus target price of $17.50.
Shares of NCI (NASDAQ:NCIT) traded down 1.92% during mid-day trading on Friday, hitting $20.40. 54,044 shares of the company’s stock traded hands. The firm has a 50-day moving average of $18.08 and a 200 day moving average of $14.94. The company has a market cap of $276.44 million, a PE ratio of 45.64 and a beta of 0.98. NCI has a 52 week low of $10.98 and a 52 week high of $21.00.
NCI (NASDAQ:NCIT) last issued its quarterly earnings data on Tuesday, May 9th. The information technology services provider reported $0.25 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.21 by $0.04. NCI had a net margin of 2.13% and a return on equity of 11.73%. The business had revenue of $78.75 million during the quarter, compared to analyst estimates of $76.55 million. Equities research analysts predict that NCI will post $1.01 EPS for the current year.
TRADEMARK VIOLATION WARNING: This story was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.com-unik.info/2017/06/17/nci-inc-ncit-given-buy-rating-at-noble-financial-updated-updated-updated.html.
Several institutional investors have recently bought and sold shares of the company. Algert Global LLC increased its position in NCI by 10.8% in the first quarter. Algert Global LLC now owns 12,155 shares of the information technology services provider’s stock worth $183,000 after buying an additional 1,180 shares during the last quarter. Hancock Holding Co. purchased a new stake in NCI during the first quarter worth approximately $189,000. Teachers Advisors LLC boosted its stake in NCI by 44.1% in the fourth quarter. Teachers Advisors LLC now owns 13,212 shares of the information technology services provider’s stock worth $184,000 after buying an additional 4,044 shares during the last quarter. Stanley Laman Group Ltd. boosted its stake in NCI by 5.5% in the third quarter. Stanley Laman Group Ltd. now owns 13,329 shares of the information technology services provider’s stock worth $154,000 after buying an additional 700 shares during the last quarter. Finally, ClariVest Asset Management LLC boosted its stake in NCI by 5.3% in the first quarter. ClariVest Asset Management LLC now owns 14,464 shares of the information technology services provider’s stock worth $217,000 after buying an additional 727 shares during the last quarter. 39.04% of the stock is currently owned by institutional investors.
NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.
What are top analysts saying about NCI Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for NCI Inc. and related companies.